Optimal Use of Fresh Frozen Plasma

Fresh frozen plasma contains a number of therapeutically useful substances, most notably coagulation factors. As with any transfusion, there are risks associated with plasma transfusion. Ironically, the risk of viral transmission (human immunodeficiency virus or hepatitis), although widely publicized, is extremely small. On the other hand, less well-known, noninfectious complications are common. Indeed, these noninfectious complications are the most significant cause of morbidity and mortality following transfusion. Although certain patients undeniably benefit from plasma transfusion, the benefit for many patients is less clear. This review will discuss indications for plasma transfusion, the associated risks, and special considerations for plasma administration.

[1]  Ognjen Gajic,et al.  Incidence and transfusion risk factors for transfusion‐associated circulatory overload among medical intensive care unit patients , 2011, Transfusion.

[2]  G. Ramsey,et al.  Approaches to minimize infection risk in blood banking and transfusion practice. , 2011, Infectious disorders drug targets.

[3]  M. Busch,et al.  Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress , 2010, Transfusion.

[4]  C. Clase,et al.  Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices , 2010, Transfusion.

[5]  K. McFann,et al.  Transfusion-related acute lung injury in ICU patients admitted with gastrointestinal bleeding , 2010, Intensive Care Medicine.

[6]  S. Rolfe,et al.  Controversies of Anticoagulation Reversal in Life-Threatening Bleeds , 2010, Journal of pharmacy practice.

[7]  E. Vamvakas,et al.  Blood Still Kills: Six Strategies to Further Reduce Allogeneic Blood Transfusion-Related Mortality , 2010, Transfusion Medicine Reviews.

[8]  M. Makris,et al.  Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient , 2010, Journal of Thrombosis and Thrombolysis.

[9]  J. Michalek,et al.  Increased Plasma and Platelet to Red Blood Cell Ratios Improves Outcome in 466 Massively Transfused Civilian Trauma Patients , 2008, Annals of surgery.

[10]  G. Walther-Wenke.  Incidence of bacterial transmission and transfusion reactions by blood components , 2008, Clinical chemistry and laboratory medicine.

[11]  M. Malinchoc,et al.  Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. , 2007, American journal of respiratory and critical care medicine.

[12]  R. Dodd.  Current risk for transfusion transmitted infections , 2007, Current opinion in hematology.

[13]  P. Toy,et al.  TRALI--definition, mechanisms, incidence and clinical relevance. , 2007, Best practice & research. Clinical anaesthesiology.

[14]  T. Lesnick,et al.  Transfusion‐related acute lung injury and pulmonary edema in critically ill patients: a retrospective study , 2006, Transfusion.

[15]  B. Healy,et al.  Effect of fresh‐frozen plasma transfusion on prothrombin time and bleeding in patients with mild coagulation abnormalities , 2006, Transfusion.

[16]  Lorne L Holland,et al.  Toward rational fresh frozen plasma transfusion: The effect of plasma transfusion on coagulation test results. , 2006, American journal of clinical pathology.

[17]  Lorne L Holland,et al.  Toward Rational Fresh Frozen Plasma Transfusion , 2006 .

[18]  C. Silliman,et al.  Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. , 2003, Blood.

[19]  H. Snooks,et al.  Can warfarin be continued during dental extraction? Results of a randomized controlled trial. , 2002, The British journal of oral & maxillofacial surgery.

[20]  R. Sorelle.  US Department of Health and Human Services gives states wider latitude in choosing services to be covered by Medicaid. , 2001, Circulation.

[21]  F. Verheugt,et al.  Oral Anticoagulant Therapy During and After Coronary Angioplasty: The Intensity and Duration of Anticoagulation Are Essential to Reduce Thrombotic Complications , 2001, Circulation.

[22]  J. Thumboo,et al.  A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium. , 1998, Arthritis and rheumatism.

[23]  D. Deziel,et al.  Laparoscopic liver biopsy in patients with coagulopathy, portal hypertension, and ascites. , 1995, The American surgeon.

[24]  P. McVay,et al.  Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities , 1991, Transfusion.

[25]  I. Sussman,et al.  Safety of invasive procedures in patients with the coagulopathy of liver disease. , 1989, Clinical and laboratory haematology.

[26]  M. Brecher,et al.  Incidence of allergic reactions with fresh frozen plasma or cryo‐supernatant plasma in the treatment of thrombotic thrombocytopenic purpura , 2001, Journal of clinical apheresis.

[27]  M. Akaike,et al.  Different secretion profiles of atrial and brain natriuretic peptides after acute volume loading in patients with ischemic heart disease. , 1997, Acta cardiologica.

[28]  A. Morice,et al.  Plasma levels of atrial natriuretic peptide and brain natriuretic peptide following intravenous saline infusion in oedematous chronic obstructive pulmonary disease and non-oedematous chronic obstructive pulmonary disease. , 1996, Respiration; international review of thoracic diseases.

[29]  P. Simcock,et al.  Management of the anticoagulated patient for ophthalmic surgery , 1993, Eye.

[30]  村上 省三.  Technical manual : 日本語版 , 1985 .